128 related articles for article (PubMed ID: 24034849)
1. [Gene therapy using a dominant negative form of the protein phosphatase 2A catalytic subunit a driven by a hepatoma tissue-specific promoter achieves effective growth inhibition of hepatoma cells].
Li DM; Li W; Tao M; Chen K; Gong FR; Xu ZK; Chen Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):459-63. PubMed ID: 24034849
[TBL] [Abstract][Full Text] [Related]
2. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
Li W; Li DM; Chen K; Chen Z; Zong Y; Yin H; Xu ZK; Zhu Y; Gong FR; Tao M
BMC Cancer; 2012 Nov; 12():547. PubMed ID: 23173703
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
5. [Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells].
Cai XK; Zhou JL; Zhou HJ; Zhang L; Wu JH; Lin JS
Ai Zheng; 2006 Nov; 25(11):1334-9. PubMed ID: 17094897
[TBL] [Abstract][Full Text] [Related]
6. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma.
Hu BG; Liu LP; Chen GG; Ye CG; Leung KK; Ho RL; Lin MC; Lai PB
Exp Cell Res; 2014 Jun; 324(2):183-91. PubMed ID: 24726886
[TBL] [Abstract][Full Text] [Related]
11. Construction of plasmid vector pAFP-HSVtk-IRES2-EGFP and its effect on the cytotoxicity of ganciclovir to hepatocellular carcinoma.
Lai Z; Qin Q; Yu B; Xie J; Gao R; Zhang T; Li C; Niu K; Xu J
Chin Med J (Engl); 2014; 127(12):2337-41. PubMed ID: 24931253
[TBL] [Abstract][Full Text] [Related]
12. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.
Ninomiya T; Mihara K; Fushimi K; Hayashi Y; Hashimoto-Tamaoki T; Tamaoki T
Hepatology; 2002 Jan; 35(1):82-7. PubMed ID: 11786962
[TBL] [Abstract][Full Text] [Related]
14. Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
Arima T; Nakao K; Nakata K; Ishikawa H; Ichikawa T; Hamasaki K; Ishii N; Eguchi K
Int J Mol Med; 2002 Apr; 9(4):397-400. PubMed ID: 11891535
[TBL] [Abstract][Full Text] [Related]
15. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
16. Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors.
Ye X; Liang M; Meng X; Ren X; Chen H; Li ZY; Ni S; Lieber A; Hu F
Biochem Biophys Res Commun; 2003 Aug; 307(4):759-64. PubMed ID: 12878174
[TBL] [Abstract][Full Text] [Related]
17. [The methylation of ZHX2 gene promoter enhances AFP gene expression in hepatocellular carcinoma].
Lv Z; DU Y; Wen J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):706-9. PubMed ID: 23837980
[TBL] [Abstract][Full Text] [Related]
18. alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.
Kawai HF; Kaneko S; Honda M; Shirota Y; Kobayashi K
Hepatology; 2001 Mar; 33(3):676-91. PubMed ID: 11230749
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
[TBL] [Abstract][Full Text] [Related]
20. [Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells].
Kuang G; Huang AL; Tang N
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):440-2. PubMed ID: 15975279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
